Boston Children's Hospital is monitoring the developing situation with lead contamination in some Boston Public Schools. Please contact your primary care physician if you have any concerns about your child.
Boston Children’s Hospital está monitoreando la situación de la contaminación por plomo en algunas escuelas públicas de Boston. Por favor, póngase en contacto con su médico primario si usted tiene alguna preocupación acerca de su hijo.
Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Sarcoidosis is an inflammatory disease that results in granulomas, which are small, rounded growths consisting of blood vessels, cells and connective tissue.
These granulomas invade different parts of the body, including the skin, bones, joints and lungs.
Sarcoidosis varies widely from person to person. Some children may experience the disease for several months, while others are affected for years-even a lifetime.
Between 30 to 70 percent of patients do not require therapy for the condition.
The Samara Jan Turkel Clinical Center for Pediatric Autoimmune Disease provides comprehensive and coordinated care and support for patients and families facing the complexities of sarcoidosis and other challenging autoimmune diseases. Clinical care includes outpatient and inpatient treatment, a wide range of rehabilitative therapies, pain management, outreach to complementary therapies such as acupuncture and massage, and developmental and psychosocial support.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”